Suppr超能文献

儿童期镰状细胞贫血患者的发育功能。

Developmental function in toddlers with sickle cell anemia.

机构信息

Department of Pediatrics (D-820), PO Box 016820, Miami, FL 33101, USA.

出版信息

Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

Abstract

BACKGROUND

Neurocognitive impairment occurs in children and adults with sickle cell anemia, but little is known about neurodevelopment in very young children. We examined the neurodevelopmental status of infants participating in the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug) to determine relationships with age, cerebral blood flow velocity, and hemoglobin concentration.

METHODS

Standardized measures of infant neurodevelopment were administered to 193 infants with hemoglobin SS or hemoglobin S-β(0) thalassemia between 7 and 18 months of age at the time of their baseline evaluation. Associations between neurodevelopmental scores and age, family income, parent education, hemoglobin concentration, and transcranial Doppler velocity were examined.

RESULTS

Mean functioning on the baseline neurodevelopment scales was in the average range. There were no mental development scores <70 (impaired); 22 children had scores in the clinically significant range, 11 with impaired psychomotor scores and 11 with problematic behavior rating scores. Significantly poorer performance was observed with older age at baseline. Behavior rating scores were an average of 2.82 percentile points lower per month of age, with similar patterns observed with parent report using adaptive behavior scales. Parent-reported functional abilities and hemoglobin were negatively associated with higher transcranial Doppler velocities.

CONCLUSIONS

Whereas overall functioning was in the normal range, behavioral and adaptive function was poorer with older age, even in this very young group of children. Explanatory mechanisms for this association between poorer developmental function and older age need to be identified.

摘要

背景

镰状细胞贫血患儿和成人会出现神经认知障碍,但对非常年幼的儿童的神经发育知之甚少。我们检查了参与小儿羟基脲 III 期临床试验(Baby Hug)的婴儿的神经发育状况,以确定其与年龄、脑血流速度和血红蛋白浓度的关系。

方法

在基线评估时,193 名血红蛋白 SS 或血红蛋白 S-β(0)地中海贫血的婴儿年龄在 7 至 18 个月之间,对其进行了标准化的婴儿神经发育评估。检查了神经发育评分与年龄、家庭收入、父母教育程度、血红蛋白浓度和经颅多普勒速度之间的关系。

结果

基线神经发育量表的平均功能处于平均范围。没有智力发育评分<70(受损);22 名儿童的评分处于临床显著范围,11 名有受损的精神运动评分,11 名有问题的行为评分。基线时年龄较大的儿童观察到的表现明显较差。行为评分平均每月降低 2.82 个百分点,使用适应行为量表进行父母报告时也观察到类似的模式。父母报告的功能能力和血红蛋白与更高的经颅多普勒速度呈负相关。

结论

尽管整体功能处于正常范围,但行为和适应功能随着年龄的增长而变差,即使在这个非常年幼的儿童群体中也是如此。需要确定这种较差的发育功能与年龄较大之间的关联的解释机制。

相似文献

1
Developmental function in toddlers with sickle cell anemia.
Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.
6
Hydroxyurea therapy in children severely affected with sickle cell disease.
J Pediatr. 1996 Jun;128(6):820-8. doi: 10.1016/s0022-3476(96)70335-9.
7
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.
Pediatr Blood Cancer. 2012 Oct;59(4):675-8. doi: 10.1002/pbc.24037. Epub 2011 Dec 20.
8
Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
Br J Haematol. 2021 Oct;195(2):256-266. doi: 10.1111/bjh.17687. Epub 2021 Jul 16.
9
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3.
10
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Cochrane Database Syst Rev. 2020 Jul 27;7(7):CD003146. doi: 10.1002/14651858.CD003146.pub4.

引用本文的文献

2
Quantifying dilated perivascular spaces in children with sickle cell disease.
Pediatr Blood Cancer. 2024 Sep;71(9):e31150. doi: 10.1002/pbc.31150. Epub 2024 Jul 2.
3
Awareness, access, and communication: provider perspectives on early intervention services for children with sickle cell disease.
Front Pediatr. 2024 Mar 25;12:1366522. doi: 10.3389/fped.2024.1366522. eCollection 2024.
4
Molecular and environmental contributors to neurological complications in sickle cell disease.
Exp Biol Med (Maywood). 2023 Aug;248(15):1319-1332. doi: 10.1177/15353702231187646. Epub 2023 Sep 9.
5
6
Interventions for chronic kidney disease in people with sickle cell disease.
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
7
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease.
Hematol Oncol Clin North Am. 2022 Dec;36(6):1167-1186. doi: 10.1016/j.hoc.2022.07.011.
8
Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
9
Adaptive Functioning in Children and Adolescents With Sickle Cell Disease.
J Pediatr Psychol. 2022 Aug 12;47(8):939-951. doi: 10.1093/jpepsy/jsac024.
10
Neurocognitive functioning in preschool children with sickle cell disease.
Pediatr Blood Cancer. 2022 Mar;69(3):e29531. doi: 10.1002/pbc.29531. Epub 2021 Dec 31.

本文引用的文献

3
Design of the silent cerebral infarct transfusion (SIT) trial.
Pediatr Hematol Oncol. 2010 Mar;27(2):69-89. doi: 10.3109/08880010903360367.
5
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.
Pediatr Blood Cancer. 2010 Feb;54(2):250-5. doi: 10.1002/pbc.22269.
6
Silent infarcts in young children with sickle cell disease.
Br J Haematol. 2009 Aug;146(3):300-5. doi: 10.1111/j.1365-2141.2009.07753.x. Epub 2009 Jun 4.
8
MRI abnormalities of the brain in one-year-old children with sickle cell anemia.
Pediatr Blood Cancer. 2008 Nov;51(5):643-6. doi: 10.1002/pbc.21612.
9
Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation.
Adv Exp Med Biol. 2006;588:189-205. doi: 10.1007/978-0-387-34817-9_17.
10
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
Blood Rev. 2007 Jan;21(1):37-47. doi: 10.1016/j.blre.2006.07.001. Epub 2006 Nov 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验